Drug Type Immunoglobulin |
Synonyms Immune globulin(Bio Products Laboratory), Subgam, Subgam-VF + [1] |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (17 Sep 2009), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Primary Immunodeficiency Diseases | United States | 17 Sep 2009 | |
Purpura, Thrombocytopenic, Idiopathic | United States | 17 Sep 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bruton Type Agammaglobulinemia | Phase 2 | Hungary | 01 Feb 2014 | |
Bruton Type Agammaglobulinemia | Phase 2 | United Kingdom | 01 Feb 2014 | |
Bruton Type Agammaglobulinemia | Phase 2 | United States | 01 Feb 2014 | |
Chronic idiopathic thrombocytopenic purpura | Phase 2 | India | 01 Sep 2007 | |
Chronic idiopathic thrombocytopenic purpura | Phase 2 | Argentina | 01 Sep 2007 | |
Chronic idiopathic thrombocytopenic purpura | Phase 2 | United States | 01 Sep 2007 | |
Common Variable Immunodeficiency | Phase 2 | United States | 01 Jan 2006 | |
Hyper-IgM Immunodeficiency Syndrome | Phase 2 | United States | 01 Jan 2006 | |
Hypogammaglobulinemia, X-Linked | Phase 2 | United States | 01 Jan 2006 | |
Wiskott-Aldrich Syndrome | Phase 2 | United States | 01 Jan 2006 |
Phase 3 | 38 | mzpajnqkmt(zciedjdpri) = zpvdnnnbtk koycifcstj (cmeislywtm, lrieowrtgp - fylqudtlpy) View more | - | 12 Sep 2018 | |||
Phase 4 | 25 | (audhwbbpsw) = klixzhbily dqhxemwqxi (jqdmlejicj, hmnhbrveji - znsyeproqd) View more | - | 23 Dec 2014 | |||
Phase 3 | 35 | ogylgjnawe(hxvhbnjioi) = rnyjvmpxpm rvvtulsiqy (knknkqmiha, rkhnwnomjx - cxckxctxgl) View more | - | 06 Jun 2012 |